AtaiBeckley ATAI
US equityBiotechnology
$0.00 +$0.00 (0.00%)
Market closed · Nov 20, 9:30 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap–
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±7.4%last 6 reports
Closed higher4 of 667% of the time
Best reaction+11.0%
Worst reaction-13.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2022/Q3 | 10 Nov 2022 | None | ±25.7% | +7.72% | Within range |
| 2022/Q2 | 15 Aug 2022 | None | ±25.1% | +2.18% | Within range |
| 2022/Q1 | 16 May 2022 | None | ±31.6% | +10.99% | Within range |
| 2021/Q4 | 30 Mar 2022 | Pre Market | ±33.2% | -1.48% | Within range |
| 2021/Q3 | 15 Nov 2021 | Pre Market | ±16.7% | -13.87% | Within range |
| 2021/Q2 | 16 Aug 2021 | Pre Market | – | +8.30% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$1.70M+137.0% YoY
Operating profit-$41.72M-65.3% YoY
Net profit-$32.55M-17.3% YoY
Diluted EPS-$0.09+35.7% YoY
Free cash flow-$35.27M-148.0% YoY
Operating cash flow-$35.27M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Operating margin-3,122.6%
Net margin-14,941.7%
Return on equity-417.5%
Return on assets-294.4%
Return on invested capital-403.9%
Current ratio8.58
Liabilities / assets33.4%
Cash & investments$225.81M
Total debt$1.57M
Net cash (debt)$224.24M
No comments yet — be the first to weigh in on ATAI.
Sign in to join the discussion.